Chronic all-trans retinoic acid administration induced hyperactivity of HPA axis and behavioral changes in young rats

European Neuropsychopharmacology

Volumn 20, Issue 12, 2010, Pages 839-847

  Cai, Li ^a,b   Yan, Xue Bo ^a   Chen, Xiao Ning ^a   Meng, Qing Yuan ^a   Zhou, Jiang Ning ^a  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Affective disorders; All trans retinoic acid; Corticotropin release factor; Hypothalamus pituitary adrenal axis

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN RELEASING FACTOR; MESSENGER RNA; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA;

ADRENAL CORTEX; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; BEHAVIOR CHANGE; BODY WEIGHT; BRAIN NERVE CELL; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; EXPLORATORY BEHAVIOR; GENE EXPRESSION; GROUPS BY AGE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS PERIVENTRICULAR NUCLEUS; MALE; MAZE TEST; MOTOR PERFORMANCE; NONHUMAN; OPEN FIELD BEHAVIOR; OPEN FIELD TEST; PRIORITY JOURNAL; RAT; TASTE PREFERENCE;

AGE FACTORS; ANIMALS; CORTICOSTERONE; DRUG ADMINISTRATION SCHEDULE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MOTOR ACTIVITY; PITUITARY-ADRENAL SYSTEM; RATS; RATS, SPRAGUE-DAWLEY; TRETINOIN;

EID: 77958166491     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2010.06.019     Document Type: Article

References (41)

1. Alexis N.E., Dietrich W.D., Green E.J., Prado R., Watson B.D. Nonocclusive common carotid artery thrombosis in the rat results in reversible sensorimotor and cognitive behavioral deficits. Stroke 1995, 26:2338-2346.
2. Bao A.M., Hestiantoro A., Van Someren E.J., Swaab D.F., Zhou J.N. Colocalization of corticotropin-releasing hormone and oestrogen receptor-alpha in the paraventricular nucleus of the hypothalamus in mood disorders. Brain 2005, 128:1301-1313.
3. Bremner J.D., Fani N., Ashraf A., Votaw J.R., Brummer M.E., Cummins T., Vaccarino V., Goodman M.M., Reed L., Siddiq S., Nemeroff C.B. Functional brain imaging alterations in acne patients treated with isotretinoin. Am. J. Psychiatry 2005, 162:983-991.
4. Cambier N., Menot M.L., Schlageter M.H., Balitrand N., Leblanc T., Bordigoni P., Rohrlich P., Lamagnère J.P., Donadieu J., Herbelin C., Puissant C., Gourand F., Baruchel A., Chomienne C. All trans retinoic acid abrogates spontaneous monocytic growth in juvenile chronic myelomonocytic leukaemia. Hematol. J. 2001, 2:97-102.
5. Carobrez A.P., Bertoglio L.J. Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20years on. Neurosci. Biobehav. Rev. 2005, 29:1193-1205.
6. Chandraratna R.A. Future trends: a new generation of retinoids. J. Am. Acad. Dermatol. 1998, 39:S149-S152.
7. Chen J., Li Y., Wang L., Zhang Z., Lu D., Lu M., Chopp M. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 2001, 32:1005-1011.
8. Chen X.N., Meng Q.Y., Bao A.M., Swaab D.F., Wang G.H., Zhou J.N. The involvement of retinoic acid receptor-alpha in corticotropin-releasing hormone gene expression and affective disorders. Biol. Psychiatry 2009, 66:832-839.
9. Combs D.J., D'Alecy L.G. Motor performance in rats exposed to severe forebrain ischemia: effect of fasting and 1,3-butanediol. Stroke 1987, 18:503-511.
10. Crettaz M., Baron A., Siegenthaler G., Hunziker W. Ligand specificities of recombinant retinoic acid receptors RAR alpha and RAR beta. Biochem. J. 1990, 272:391-397.
11. de Oliveira M.R., Silvestrin R.B., Mello E.S.T., Moreira J.C. Oxidative stress in the hippocampus, anxiety-like behavior and decreased locomotory and exploratory activity of adult rats: effects of sub acute vitamin A supplementation at therapeutic doses. Neurotoxicology 2007, 28:1191-1199.
12. Feeney D.M., Gonzalez A., Law W.A. Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury. Science 1982, 217:855-857.
13. Ferguson S.A., Cisneros F.J., Gough B., Hanig J.P., Berry K.J. Chronic oral treatment with 13-cis-retinoic acid (isotretinoin) or all-trans-retinoic acid does not alter depression-like behaviors in rats. Toxicol. Sci. 2005, 87:451-459.
14. Ferguson S.A., Cisneros F.J., Hanig J.P., Berry K.J. Oral treatment with ACCUTANE does not increase measures of anhedonia or depression in rats. Neurotoxicol. Teratol. 2007, 29:642-651.
15. Fiorella P.D., Giguere V., Napoli J.L. Expression of cellular retinoic acid-binding protein (type II) in Escherichia coli. Characterization and comparison to cellular retinoic acid-binding protein (type I). J. Biol. Chem. 1993, 268:21545-21552.
16. Geiger J.M., Hommel L., Harms M., Saurat J.H. Oral 13-cis retinoic acid is superior to 9-cis retinoic acid in sebosuppression in human beings. J. Am. Acad. Dermatol. 1996, 34:513-515.
17. Huang Q., Zhu H., Fischer D.F., Zhou J.N. An estrogenic effect of 5alpha-androstane-3beta, 17beta-diol on the behavioral response to stress and on CRH regulation. Neuropharmacology 2008, 54:1233-1238.
18. Hull P.R., D'Arcy C. Acne, depression, and suicide. Dermatol. Clin. 2005, 23:665-674.
19. Krezel W., Kastner P., Chambon P. Differential expression of retinoid receptors in the adult mouse central nervous system. Neuroscience 1999, 89:1291-1300.
20. Lane M.A., Bailey S.J. Role of retinoid signalling in the adult brain. Prog. Neurobiol. 2005, 75:275-293.
21. Le Douze F., Debruyne D., Albessard F., Barre L., Defer G.L. Pharmacokinetics of all-trans retinoic acid, 13-cis retinoic acid, and fenretinide in plasma and brain of rat. Drug Metab. Dispos. 2000, 28:205-208.
22. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
23. Luo T., Wagner E., Grun F., Drager U.C. Retinoic acid signaling in the brain marks formation of optic projections, maturation of the dorsal telencephalon, and function of limbic sites. J. Comp. Neurol. 2004, 470:297-316.
24. Maden M. Retinoic acid in the development, regeneration and maintenance of the nervous system. Nat. Rev. Neurosci. 2007, 8:755-765.
25. McCaffery P.J., Adams J., Maden M., Rosa-Molinar E. Too much of a good thing: retinoic acid as an endogenous regulator of neural differentiation and exogenous teratogen. Eur. J. Neurosci. 2003, 18:457-472.
26. O'Reilly K.C., Shumake J., Gonzalez-Lima F., Lane M.A., Bailey S.J. Chronic administration of 13-cis-retinoic acid increases depression-related behavior in mice. Neuropsychopharmacology 2006, 31:1919-1927.
27. O'Reilly K., Bailey S.J., Lane M.A. Retinoid-mediated regulation of mood: possible cellular mechanisms. Exp. Biol. Med. 2008, 233:251-258.
28. Owens M.J., Nemeroff C.B. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol. Rev. 1991, 43:425-473.
29. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1998, Academic Press, Spiral Bound, New York. Fourth Edition.
30. Ramos A., Mormede P. Stress and emotionality: a multidimensional and genetic approach. Neurosci. Biobehav. Rev. 1998, 22:33-57.
31. Spear L.P. The adolescent brain and age-related behavioral manifestations. Neurosci. Biobehav. Rev. 2000, 24:417-463.
32. Starling J., Koo J. Evidence based or theoretical concern? Pseudotumor cerebri and depression as acitretin side effects. J. Drugs Dermatol. 2005, 4:690-696.
33. Stokes P.E., Sikes C.R. Hypothalamic-pituitary-adrenal axis in psychiatric disorders. Annu. Rev. Med. 1991, 42:519-531.
34. Swaab D.F., Bao A.M., Lucassen P.J. The stress system in the human brain in depression and neurodegeneration. Ageing Res. Rev. 2005, 4:141-194.
35. Tafti M., Ghyselinck N.B. Functional implication of the vitamin A signaling pathway in the brain. Arch. Neurol. 2007, 64:1706-1711.
36. Trent S., Drew C.J., Mitchell P.J., Bailey S.J. Chronic treatment with 13-cis-retinoic acid changes aggressive behaviours in the resident-intruder paradigm in rats. Eur. Neuropsychopharmacol. 2009, 19:876-886.
37. Wu L.M., Han H., Wang Q.N., Hou H.L., Tong H., Yan X.B., Zhou J.N. Mifepristone repairs region-dependent alteration of synapsin I in hippocampus in rat model of depression. Neuropsychopharmacology 2007, 32:2500-2510.
38. Yan X.B., Wang S.S., Hou H.L., Ji R., Zhou J.N. Lithium improves the behavioral disorder in rats subjected to transient global cerebral ischemia. Behav. Brain. Res. 2007, 177:282-289.
39. Yasin S.A., Costa A., Besser G.M., Hucks D., Grossman A., Forsling M.L. Melatonin and its analogs inhibit the basal and stimulated release of hypothalamic vasopressin and oxytocin in vitro. Endocrinology 1993, 132:1329-1336.
40. Zetterstrom R.H., Lindqvist E., Mata de Urquiza A., Tomac A., Eriksson U., Perlmann T., Olson L. Role of retinoids in the CNS: differential expression of retinoid binding proteins and receptors and evidence for presence of retinoic acid. Eur. J. Neurosci. 1999, 11:407-416.
41. Zouboulis C.C., Piquero-Martin J. Update and future of systemic acne treatment. Dermatology 2003, 206:37-53.